Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

AVEO Pharmaceuticals Price to Sales Ratio 2009-2019 | AVEO

Historical PS ratio values for AVEO Pharmaceuticals (AVEO) over the last 10 years. The current P/S ratio for AVEO Pharmaceuticals as of January 22, 2020 is .
  
AVEO Pharmaceuticals P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2020-01-23 0.60 3.22
2019-09-30 0.84 $0.19 4.50
2019-06-30 0.67 $0.05 13.90
2019-03-31 0.82 $0.05 17.31
2018-12-31 1.60 $0.04 36.47
2018-09-30 3.31 $0.03 99.38
2018-06-30 2.26 $0.05 43.57
2018-03-31 2.90 $0.05 56.11
2017-12-31 2.79 $0.08 36.59
2017-09-30 3.65 $0.08 47.21
2017-06-30 2.22 $0.05 43.28
2017-03-31 0.59 $0.05 11.57
2016-12-31 0.54 $0.04 14.03
2016-09-30 0.89 $0.10 8.79
2016-06-30 0.96 $0.35 2.71
2016-03-31 0.92 $0.35 2.60
2015-12-31 1.26 $0.34 3.76
2015-09-30 1.21 $0.27 4.43
2015-06-30 1.74 $0.02 72.39
2015-03-31 1.45 $0.06 25.29
2014-12-31 0.84 $0.35 2.39
2014-09-30 1.11 $0.36 3.13
2014-06-30 1.83 $0.34 5.31
2014-03-31 1.50 $0.32 4.75
2013-12-31 1.83 $0.03 71.83
2013-09-30 2.06 $0.38 5.46
2013-06-30 2.50 $0.39 6.34
2013-03-31 7.35 $0.43 17.04
2012-12-31 8.05 $0.44 18.10
2012-09-30 10.41 $0.11 92.06
2012-06-30 12.16 $0.17 70.30
2012-03-31 12.41 $0.85 14.60
2011-12-31 17.20 $4.40 3.91
2011-09-30 15.39 $4.84 3.18
2011-06-30 20.61 $4.95 4.16
2011-03-31 13.32 $4.74 2.81
2010-12-31 14.62 $2.89 5.06
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.097B $0.005B
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company's lead product candidate, is a highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2 and 3. In addition to tivozanib, AVEO Pharmaceuticals has a pipeline of monoclonal antibodies derived from Human Response Platform (HRP), a novel method of building preclinical models of human cancer, which are intended to more accurately represent cancer biology in patients. AV-299 is the Company's next product candidate which is an antibody that binds to hepatocyte growth factor, or HGF, thereby blocking its function. AVEO Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.673B 16.20
CSL (CSLLY) Australia $95.121B 0.00
Gilead Sciences (GILD) United States $80.248B 9.94
Vertex Pharmaceuticals (VRTX) United States $60.330B 61.58
Biogen (BIIB) United States $51.985B 8.92
Illumina (ILMN) United States $48.657B 53.39
Regeneron Pharmaceuticals (REGN) United States $39.431B 17.27
Alexion Pharmaceuticals (ALXN) United States $24.652B 12.18
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.764B 0.00
Seattle Genetics (SGEN) United States $19.144B 0.00
Incyte (INCY) United States $16.904B 39.24
BioMarin Pharmaceutical (BMRN) United States $15.733B 0.00
Genmab (GNMSF) Denmark $14.047B 62.04
Galapagos (GLPG) Belgium $12.910B 33.26
Alnylam Pharmaceuticals (ALNY) United States $12.892B 0.00
Exact Sciences (EXAS) United States $12.329B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
BeiGene (BGNE) Cayman Islands $10.338B 0.00
Sarepta Therapeutics (SRPT) United States $8.821B 0.00
BioNTech SE (BNTX) Germany $8.797B 0.00
Bio-Techne Corp (TECH) United States $8.353B 55.91
Guardant Health (GH) United States $7.945B 0.00
QIAGEN (QGEN) Netherlands $7.854B 25.61
Amarin (AMRN) Ireland $7.437B 0.00
Moderna (MRNA) United States $7.322B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.222B 18.36
ACADIA Pharmaceuticals (ACAD) United States $6.494B 0.00
Reata Pharmaceuticals (RETA) United States $6.349B 0.00
Exelixis (EXEL) United States $5.992B 16.85
ARGENX SE-ADR (ARGX) Netherlands $5.850B 0.00
Ascendis Pharma (ASND) Denmark $5.629B 0.00
Repligen (RGEN) United States $5.250B 95.14
Bluebird Bio (BLUE) United States $5.190B 0.00
China Biologic Products (CBPO) China $4.584B 25.82
MorphoSys AG (MOR) Germany $4.195B 0.00
Immunomedics (IMMU) United States $3.639B 0.00
Mirati Therapeutics (MRTX) United States $3.588B 0.00
NeoGenomics (NEO) United States $3.444B 183.28
Blueprint Medicines (BPMC) United States $3.435B 0.00
Adaptive Biotechnologies (ADPT) United States $3.381B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.377B 0.00
MyoKardia (MYOK) United States $3.301B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.241B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.223B 0.00
Emergent Biosolutions (EBS) United States $3.017B 29.97
Genmab (GMAB) Denmark $2.977B 6.13
Alkermes (ALKS) Ireland $2.927B 0.00
Halozyme Therapeutics (HALO) United States $2.865B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.831B 0.00
Zai Lab (ZLAB) China $2.817B 0.00
Acceleron Pharma (XLRN) United States $2.813B 0.00
UniQure (QURE) Netherlands $2.678B 0.00
Amicus Therapeutics (FOLD) United States $2.469B 0.00
Epizyme (EPZM) United States $2.323B 0.00
Arena Pharmaceuticals (ARNA) United States $2.295B 5.34
Denali Therapeutics (DNLI) United States $2.247B 0.00
RA PHARMCTL INC (RARX) United States $2.210B 0.00
Myriad Genetics (MYGN) United States $2.134B 31.53
Zymeworks (ZYME) Canada $1.961B 0.00
Principia Biopharma (PRNB) United States $1.961B 0.00
Fate Therapeutics (FATE) United States $1.856B 0.00
Insmed (INSM) United States $1.807B 0.00
Akcea Therapeutics (AKCA) United States $1.807B 0.00
REGENXBIO (RGNX) United States $1.725B 0.00
Arvinas (ARVN) United States $1.712B 0.00
Ligand Pharmaceuticals (LGND) United States $1.602B 30.81
Alector (ALEC) United States $1.580B 0.00
Editas Medicine (EDIT) United States $1.541B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.475B 0.00
Intra-Cellular Therapies (ITCI) United States $1.414B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.362B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.343B 0.00
Coherus BioSciences (CHRS) United States $1.332B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.190B 0.00
Zealand Pharma (ZEAL) Denmark $1.177B 0.00
DBV Technologies S.A (DBVT) France $1.092B 0.00
Codexis (CDXS) United States $1.024B 0.00
Revance Therapeutics (RVNC) United States $1.001B 0.00
Mesoblast (MESO) Australia $0.996B 0.00
PHARMA MAR SA (PHMMF) Spain $0.965B 0.00
Sangamo Therapeutics (SGMO) United States $0.950B 0.00
Pharming Group (PHGUF) Netherlands $0.926B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.902B 0.00
Heska (HSKA) United States $0.836B 213.66
ZIOPHARM Oncology Inc (ZIOP) United States $0.811B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.801B 6.74
GENFIT S.A (GNFT) France $0.763B 0.00
Adverum Biotechnologies (ADVM) United States $0.763B 0.00
Twist Bioscience (TWST) United States $0.762B 0.00
Vericel (VCEL) United States $0.753B 280.83
ANI Pharmaceuticals (ANIP) United States $0.749B 12.77
Cellectis S.A (CLLS) France $0.744B 0.00
Cytokineticsorporated (CYTK) United States $0.741B 0.00
Intellia Therapeutics (NTLA) United States $0.716B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
NantKwest (NK) United States $0.711B 0.00
Sorrento Therapeutics (SRNE) United States $0.698B 0.00
Retrophin (RTRX) United States $0.693B 0.00
Anika Therapeutics (ANIK) United States $0.652B 21.16
Cara Therapeutics (CARA) United States $0.652B 0.00
AC Immune SA (ACIU) Switzerland $0.652B 15.08
UROGEN PHARMA (URGN) United States $0.635B 0.00
Kadmon Holdings (KDMN) United States $0.602B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.568B 0.00
Prothena (PRTA) Ireland $0.555B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.553B 0.00
Agenus (AGEN) United States $0.550B 0.00
Precision BioSciences (DTIL) United States $0.521B 0.00
BioDelivery Sciences (BDSI) United States $0.513B 0.00
Clovis Oncology (CLVS) United States $0.501B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.501B 0.00
Cel-Sci (CVM) United States $0.495B 0.00
Dynavax Technologies (DVAX) United States $0.484B 0.00
Bellus Health (BLU) Canada $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Arcus Biosciences (RCUS) United States $0.456B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.435B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.419B 0.00
AnaptysBio (ANAB) United States $0.408B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.401B 2.77
Merus (MRUS) Netherlands $0.401B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.392B 0.00
Kindred Biosciences (KIN) United States $0.386B 0.00
Gritstone Oncology (GRTS) United States $0.370B 0.00
PDL BioPharma (PDLI) United States $0.368B 9.20
Mersana Therapeutics (MRSN) United States $0.367B 0.00
Avid Bioservices (CDMO) United States $0.362B 0.00
Pfenex (PFNX) United States $0.361B 0.00
Puma Biotechnology (PBYI) United States $0.356B 0.00
Cue Biopharma (CUE) United States $0.353B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Stemline Therapeutics (STML) United States $0.349B 0.00
MannKind (MNKD) United States $0.349B 0.00
Syros Pharmaceuticals (SYRS) United States $0.348B 0.00
OSMOTICA PHARM (OSMT) United States $0.345B 0.00
Inovio Pharmaceuticals (INO) United States $0.344B 0.00
CytomX Therapeutics (CTMX) United States $0.335B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
Compugen (CGEN) Israel $0.318B 0.00
Albireo Pharma (ALBO) United States $0.305B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
IVERIC Bio (ISEE) United States $0.291B 0.00
Geron (GERN) United States $0.284B 0.00
Kamada (KMDA) Israel $0.277B 8.11
Sutro Biopharma (STRO) United States $0.277B 0.00
ADMA Biologics Inc (ADMA) United States $0.271B 0.00
WAVE Life Sciences (WVE) Singapore $0.266B 0.00
Prometic Life Sciences (LMNL) Canada $0.262B 0.00
VBI Vaccines (VBIV) United States $0.260B 0.00
ChromaDex (CDXC) United States $0.259B 0.00
Biofrontera AG (BFRA) Germany $0.254B 0.00
Seres Therapeutics (MCRB) United States $0.242B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.231B 0.00
Exicure (XCUR) United States $0.229B 0.00
Novavax (NVAX) United States $0.228B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.224B 0.00
Affimed (AFMD) Germany $0.221B 0.00
Theratechnologies (THTX) Canada $0.220B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.218B 0.00
XOMA (XOMA) United States $0.212B 0.00
Cerecor (CERC) United States $0.211B 0.00
Protagonist Therapeutics (PTGX) United States $0.208B 0.00
Five Prime Therapeutics (FPRX) United States $0.207B 0.00
Athersys (ATHX) United States $0.202B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.200B 0.00
Arbutus Biopharma (ABUS) Canada $0.199B 0.00
Fortress Biotech (FBIO) United States $0.198B 0.00
Spero Therapeutics (SPRO) United States $0.188B 0.00
Alcobra (ARCT) United States $0.187B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.184B 0.00
Applied Genetic Technologies (AGTC) United States $0.180B 0.00
TELA Bio (TELA) United States $0.177B 0.00
CorMedix Inc (CRMD) United States $0.175B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.174B 0.00
Aptinyx (APTX) United States $0.169B 0.00
Selecta Biosciences (SELB) United States $0.169B 0.00
Palatin Technologies (PTN) United States $0.163B 4.44
Strongbridge Biopharma (SBBP) United States $0.161B 4.30
ARAVIVE, INC (ARAV) United States $0.159B 0.00
PHASEBIO PHARMA (PHAS) United States $0.157B 0.00
Dyadic (DYAI) United States $0.156B 0.00
Windtree Therapeutics (WINT) United States $0.148B 0.00
Menlo Therapeutics (MNLO) United States $0.148B 0.00
Abeona Therapeutics (ABEO) United States $0.146B 0.00
Verastem (VSTM) United States $0.142B 0.00
VTv Therapeutics (VTVT) United States $0.140B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Liquidia Technologies (LQDA) United States $0.131B 0.00
Northwest Biotherapeutics (NWBO) United States $0.124B 0.00
Enzo Biochem (ENZ) United States $0.124B 0.00
Arsanis (XFOR) United States $0.124B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.122B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.121B 6.23
Clearside Biomedical (CLSD) United States $0.121B 0.00
Aduro Biotech (ADRO) United States $0.119B 0.00
Happiness Biotech Group (HAPP) China $0.115B 0.00
Celyad SA (CYAD) Belgium $0.115B 0.00
Antibe Therapeutics (ATBPF) Canada $0.110B 0.00
OvaScience (MLND) United States $0.108B 0.00
Acorda Therapeutics (ACOR) United States $0.099B 0.00
SESEN BIO, INC (SESN) United States $0.098B 0.00
Proteostasis Therapeutics (PTI) United States $0.096B 0.00
AIT Therapeutics (XAIR) United States $0.095B 0.00
Synlogic (SYBX) United States $0.093B 0.00
Catalyst Biosciences (CBIO) United States $0.087B 0.00
Adocia (ADOCY) France $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Trevena (TRVN) United States $0.083B 0.00
Orgenesis (ORGS) United States $0.082B 5.31
Catabasis Pharmaceuticals (CATB) United States $0.082B 0.00
Prima BioMed (IMMP) Australia $0.080B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Vaccinex (VCNX) United States $0.079B 0.00
Checkpoint Therapeutics (CKPT) United States $0.076B 0.00
NewLink Genetics (NLNK) United States $0.076B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.058B 0.00
Curis (CRIS) United States $0.057B 0.00
Idera Pharmaceuticals (IDRA) United States $0.056B 0.00
DiaMedica Therapeutics (DMAC) United States $0.051B 0.00
Soligenix (SNGX) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Organovo Holdings (ONVO) United States $0.047B 0.00
Evogene (EVGN) Israel $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.043B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
BioCardia (BCDA) United States $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
Unum Therapeutics (UMRX) United States $0.036B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Bionano Genomics (BNGO) United States $0.032B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
VIVUS (VVUS) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.028B 0.00
AmpliPhi Biosciences (ARMP) United States $0.027B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Stellar Biotechnologies (EDSA) Canada $0.025B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
Signal Genetics (MGEN) United States $0.019B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Advaxis (ADXS) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
IBio (IBIO) United States $0.009B 0.00
BioPharmX (BPMX) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.005B 0.00